Cargando…

Evaluation of adjuvant therapy in women with uterine papillary serous cancer

BACKGROUND AND OBJECTIVE: Uterine papillary serous cancer (UPSC) represents only 10% of all uterine cancers and is associated with a significantly worse prognosis compared with other histological types of endometrial cancers. It closely resembles the behavior of ovarian carcinoma. DESIGN AND SETTING...

Descripción completa

Detalles Bibliográficos
Autores principales:	Al Husaini, Hamed, Soudy, Hussein, Darwish, Alaa, Ahmed, Mohamed, Eltigani, Amin, Edesa, Wael, Abdelsalam, Mahmoud
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	King Faisal Specialist Hospital and Research Centre 2012
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6087649/ https://www.ncbi.nlm.nih.gov/pubmed/22156636 http://dx.doi.org/10.5144/0256-4947.2012.27

Ejemplares similares

Papillary Serous Carcinoma of the Uterine Cervix with Lung Metastasis
por: Khan, Maliha, et al.
Publicado: (2014)

Management of Women with Surgically Staged 1 Uterine Papillary Serous Cancer
por: Elit, Laurie, et al.
Publicado: (2011)

Cytologic Findings of Cervicovaginal Smears in Women with Uterine Papillary Serous Carcinoma
por: Park, Ji-Young, et al.
Publicado: (2005)

Discrimination between uterine serous papillary carcinomas and ovarian serous papillary tumours by gene expression profiling
por: Santin, A D, et al.
Publicado: (2004)

The Impact of Adjuvant Management Strategies on Outcomes in Women With Early Stage Uterine Serous Carcinoma
por: Cook, Andrew, et al.
Publicado: (2021)

Which is worse: uterine papillary serous carcinomas or carcinosarcomas?
por: Song, Taejong, et al.
Publicado: (2011)

Adrenal Metastasis from Uterine Papillary Serous Carcinoma
por: Lubana, Sandeep Singh, et al.
Publicado: (2016)

Metastatic papillary serous uterine cancer presenting as a rash
por: Chang, Eric S., et al.
Publicado: (2016)

Survival of women with clear cell and papillary serous endometrial cancer after adjuvant radiotherapy
por: Foerster, Robert, et al.
Publicado: (2014)

Gene expression fingerprint of uterine serous papillary carcinoma: identification of novel molecular markers for uterine serous cancer diagnosis and therapy
por: Santin, A D, et al.
Publicado: (2005)

In vitro activity of pertuzumab in combination with trastuzumab in uterine serous papillary adenocarcinoma
por: El-Sahwi, K, et al.
Publicado: (2010)

Combined modality therapy in the adjuvant treatment of uterine serous carcinoma
por: Block, Alec M., et al.
Publicado: (2016)

Excellent Response to Palliative Chemotherapy for Pleural Recurrence of Uterine Papillary Serous Carcinoma
por: Singh, Shantanu, et al.
Publicado: (2013)

Serum amyloid A (SAA): a novel biomarker for uterine serous papillary cancer
por: Cocco, E, et al.
Publicado: (2009)

Combined Adjuvant Chemotherapy and Radiation Therapy Improves Disease-Free Survival for Uterine Serous Cancer
por: Arden, Jessica D., et al.
Publicado: (2020)

Clinicopathological Characteristics and Her-2/neu Status in Chinese Patients with Uterine Papillary Serous Carcinoma
por: Ren, Yulan, et al.
Publicado: (2011)

The impact of combined radiation and chemotherapy on outcome in uterine papillary serous carcinoma compared to chemotherapy alone
por: Mahdi, Haider, et al.
Publicado: (2016)

Prognostic factors for patients with early-stage uterine serous carcinoma without adjuvant therapy
por: Tate, Keisei, et al.
Publicado: (2018)

Stage I Clear Cell and Serous Uterine Carcinoma: What Is the Right Adjuvant Therapy?
por: Lefebvre, Manon, et al.
Publicado: (2023)

Anaphylaxis Induced by Sugammadex in a Patient with Papillary Serous Carcinoma of the Uterine Adnexa Undergoing Exploratory Laparotomy
por: Escher, Allan R, et al.
Publicado: (2019)

Clinicopathological and survival analysis of uterine papillary serous carcinoma: a single institutional review of 106 cases
por: Wang, Yao, et al.
Publicado: (2018)

Can morphometric analysis of the fallopian tube fimbria predict the presence of uterine papillary serous carcinoma (UPSC)?
por: Amit, Amnon, et al.
Publicado: (2019)

The Use of Antidiabetic, Antihypertensive, and Lipid-lowering Medications in the Elderly Dying with Advanced Cancer
por: Al-Shahri, Mohammad Zafir, et al.
Publicado: (2019)

Abdominal Wall Metastasis of Uterine Papillary Serous Carcinoma in a Post-Menopausal Woman: A Case Report
por: Park, Jung-Woo, et al.
Publicado: (2014)

Rare brain metastasis with unusual characteristics in a late recurrence of stage IIIA uterine papillary serous carcinoma
por: Crain, Charles Nicolas, et al.
Publicado: (2021)

Survival outcomes of adjuvant radiotherapy and chemotherapy in women with stage I serous papillary and clear cell carcinoma of the endometrium: a Korean multicenter study
por: Kim, Miseon, et al.
Publicado: (2019)

Uterine papillary serous and clear cell carcinomas predict for poorer survival compared to grade 3 endometrioid corpus cancers
por: Hamilton, C A, et al.
Publicado: (2006)

Advanced papillary serous carcinoma of the uterine cervix: a case with a remarkable response to paclitaxel and carboplatin combination chemotherapy
por: Ueda, Masashi, et al.
Publicado: (2011)

An analysis of current treatment practice in uterine papillary serous and clear cell carcinoma at two high volume cancer centers
por: Vogel, Tilley Jenkins, et al.
Publicado: (2015)

A novel model to predict cancer‐specific survival in patients with early‐stage uterine papillary serous carcinoma (UPSC)
por: Chen, Lihua, et al.
Publicado: (2019)

Brain Metastasis in Papillary Serous Adenocarcinoma of the Endometrium
por: Eulálio Filho, Walberto Monteiro Neiva, et al.
Publicado: (2019)

Paratesticular Serous Papillary Carcinoma of High Grade and Malignant Potential: A Rare Case with a Role for Adjuvant Therapy
por: Lifton, Jacob, et al.
Publicado: (2018)

Multiple brain metastases in a patient with uterine papillary serous adenocarcinoma: Treatment options for this rarely seen metastatic brain tumor
por: Gulsen, Salih, et al.
Publicado: (2013)

The incidence of pelvic and para-aortic lymph node metastasis in uterine papillary serous and clear cell carcinoma according to the SEER registry
por: Mattes, Malcolm D., et al.
Publicado: (2015)

PLK3 amplification and tumor immune microenvironment of metastatic tumors are linked to adjuvant treatment outcomes in uterine serous cancer
por: Jones, Wendell, et al.
Publicado: (2022)

Pathogenesis and Clinical Management of Uterine Serous Carcinoma
por: Zhang, Li, et al.
Publicado: (2020)

A case of synchronous serous ovarian cancer and uterine serous endometrial intraepithelial carcinoma
por: Shimizu, Maho, et al.
Publicado: (2021)

Serous papillary cystadenofibroma of vulva: A histopathological surprise
por: Roshini, A.P., et al.
Publicado: (2021)

HER2 Oncogene as Molecular Target in Uterine Serous Carcinoma and Uterine Carcinosarcoma
por: McNamara, Blair, et al.
Publicado: (2023)

Impact of positive cytology in uterine serous carcinoma: A reassessment
por: Corey, Logan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_f99bpqn6eenrq9org8khp43i2b